About this item
Product details
Wegovy 1.7 mg is a prescription glucagon‑like peptide‑1 (GLP‑1) receptor agonist pen used as the fourth step in the standard 16‑week dose‑escalation schedule for chronic weight management. It is indicated for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight‑related comorbidity, and to reduce cardiovascular risk in adults with established cardiovascular disease and BMI ≥27 {start of citation}1{end of citation}. The 1.7 mg dose is taken once weekly during weeks 13‑16 of treatment as the final step‑up dose before reaching the 2.4 mg maintenance dose. Final Titration Dose Before Maintenance: The 1.7 mg dose (weeks 13‑16) is the fourth and final step‑up dose in the Wegovy titration schedule, preparing patients for the transition to the 2.4 mg once‑weekly maintenance dose from week 17 onward Foundation for Clinically Proven Weight Loss: When followed through to the 2.4 mg maintenance dose, Wegovy produced a mean weight loss of up to 15.6% in the STEP UP trial, with the 1.7 mg dose playing a critical role in the gradual dose escalation that minimizes gastrointestinal side effects Reduces Cardiovascular Risk (as part of full regimen): When continued to the 2.4 mg maintenance dose, semaglutide is proven to reduce the risk of major adverse cardiovascular events (cardiovascular death, non‑fatal heart attack, or non‑fatal stroke) by 20% in adults with established cardiovascular disease and BMI ≥27 kg/m² Once‑Weekly, Flexible Dosing: Administer subcutaneously once weekly in the abdomen, thigh, or upper arm, at any time of day, with or without meals Composition Each prefilled pen contains 6.8 mg semaglutide in 3 mL (2.27mg/mL) Directions for Use Use as prescribed by the physician.
- Medicines
- 1 x 3mL pen & 4 disposable needles
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Novo Nordisk
- SKU
- 05712249132804
- Variant
- 1 x 3mL pen & 4 disposable needles
- Tags
- Diabetes, Heart, Heart Support, Insulin, Medicine, Semaglutide, Type 2 Diabetes, Weight Loss
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
